The focus of the debates surrounding the Medical Innovation Bill and Access to Medical Treatments (Innovation) Act 2015 was the negligence provisions. This paper examines the other aspect that was consequently ignored: the proposed database of innovative treatments of Lord Saatchi’s Bill. It is argued that some aspects of the database require rethinking, but that its biggest problem lies in the lack of stakeholder clamour for it.
History
Citation
Law, Innovation and Technology
Author affiliation
/Organisation/COLLEGE OF SOCIAL SCIENCES, ARTS AND HUMANITIES/Leicester Law School
The file associated with this record is under embargo until 18 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.